Detalles de la búsqueda
1.
Disease-modifying effects of a glial-targeted inducible nitric oxide synthase inhibitor (1400W) in mixed-sex cohorts of a rat soman (GD) model of epilepsy.
J Neuroinflammation
; 20(1): 163, 2023 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37438764
2.
Disease-Modifying Effects of a Glial-targeted Inducible Nitric Oxide Synthase Inhibitor (1400W) in Mixed-sex Cohorts of a Rat Soman (GD) Model of Epilepsy.
Res Sq
; 2023 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37214912
3.
DFP-Induced Status Epilepticus Severity in Mixed-Sex Cohorts of Adult Rats Housed in the Same Room: Behavioral and EEG Comparisons.
Front Cell Dev Biol
; 10: 895092, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35620057
4.
Differential Impact of Severity and Duration of Status Epilepticus, Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosphate Model.
Front Cell Neurosci
; 15: 772868, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34720886
5.
Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress.
Antioxidants (Basel)
; 11(1)2021 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35052568
Resultados
1 -
5
de 5
1
Próxima >
>>